Oral and Anal Swab Sampling in Patients With HPV Positivity (Oral Anal HPV)

Medipol University

Status: Completed

Conditions: HPV

Treatments: Diagnostic Test: HPV testing

Study type: Observational

Funder types: Other

Identifiers

NCT06906913

Number 362

TF.HZP.23.31 (Other Grant/Funding Number)

Details and patient eligibility

About

Patients whose pathology results are reported as cervical intraepithelial neoplasia (CIN) 1, CIN 2, and CIN 3, are recruited. We aimed to evaluate HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, by collecting oropharyngeal and anal swab samples. A total of 30 women of reproductive age, who consented to participate, were included in the study.

Full description

Human papillomavirus (HPV) positivity is associated with cervical, oropharyngeal, and anal cancers. There is insufficient data in the current literature regarding the effectiveness of obtaining oropharyngeal and anal swabs from patients with HPV positivity is an effective method for detecting potential pathologies. HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, will be evaluated by collecting oropharyngeal and anal swab samples.

Enrollment: 30 patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3

Exclusion criteria

• HPV-negative women

Trial design

30 participants in 1 patient group

Swab Sampling

Description:

Oropharyngeal and anal swab samples are obtained.

Treatment:

Diagnostic Test: HPV testing